JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

Search

Cogent Biosciences Inc

Închisă

12.08 -0.33

Rezumat

Modificarea prețului

24h

Curent

Minim

11.92

Maxim

12.13

Indicatori cheie

By Trading Economics

Venit

-4.1M

-72M

Angajați

205

EBITDA

-1.2M

-74M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+62.72% upside

Dividende

By Dow Jones

Următoarele câștiguri

5 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

1.1B

1.7B

Deschiderea anterioară

12.41

Închiderea anterioară

12.08

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Cogent Biosciences Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

25 iul. 2025, 17:53 UTC

Principalele dinamici ale pieței

Genworth Shares Rise On UK Court Ruling That Could Lead to $750 Million Windfall

25 iul. 2025, 15:58 UTC

Câștiguri
Principalele dinamici ale pieței

Aon Shares Rise After 2Q Earnings Beat

25 iul. 2025, 15:08 UTC

Principalele dinamici ale pieței

AST SpaceMobile Shares Slide After Convertible Notes, Stock Offerings

25 iul. 2025, 21:40 UTC

Market Talk

Starbucks' Spending Hikes Are Misdirected -- Market Talk

25 iul. 2025, 21:23 UTC

Market Talk

Honeywell's Growth Seen Holding Up Despite Recent Headwinds -- Market Talk

25 iul. 2025, 20:40 UTC

Câștiguri

Tesla Stock Is Rising. Robo-taxi Trumps a Lack of New Models. -- Barrons.com

25 iul. 2025, 20:10 UTC

Câștiguri

These Stocks Moved the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Tesla, and More -- Barrons.com

25 iul. 2025, 19:56 UTC

Câștiguri

Correction to Why Bargain Hunters Are Flocking to 'Bin Stores' -- Barrons.com on July 20

25 iul. 2025, 19:14 UTC

Market Talk

Oil Futures Post Back-to-Back Weekly Losses -- Market Talk

25 iul. 2025, 19:10 UTC

Market Talk

U.S. Natural Gas Futures Appear to Stabilize -- Market Talk

25 iul. 2025, 19:01 UTC

Câștiguri

These Stocks Are Moving the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Tesla, and More -- Barrons.com

25 iul. 2025, 18:45 UTC

Market Talk

Gold Ends Down Week on Lower Note -- Market Talk

25 iul. 2025, 18:35 UTC

Achiziții, Fuziuni, Preluări

Sale Could Fetch Around $1B, Sources Say -- WSJ

25 iul. 2025, 18:35 UTC

Achiziții, Fuziuni, Preluări

LVMH in Talks to Sell Marc Jacobs -- WSJ

25 iul. 2025, 18:35 UTC

Achiziții, Fuziuni, Preluări

Suitors for Marc Jacobs Include Authentic, Bluestar Alliance and WHP Global, Sources Say -- WSJ

25 iul. 2025, 18:35 UTC

Achiziții, Fuziuni, Preluări

LVMH Exploring Sale of Fashion Brand Marc Jacobs, Sources Say -- WSJ

25 iul. 2025, 17:38 UTC

Principalele dinamici ale pieței

Genworth Shares Rise On UK Court Ruling That Could Lead to $750M Windfall

25 iul. 2025, 17:26 UTC

Market Talk

U.S. Oil Rig Count Extends Decline -- Market Talk

25 iul. 2025, 17:13 UTC

Câștiguri

Tesla Stock Is Rising. Robo-taxi Trumps a Lack of New Models. -- Barrons.com

25 iul. 2025, 16:46 UTC

Câștiguri

Volkswagen Teases Made-in-America Audis, Porsches After $1.5 Billion Tariff Hit -- 2nd Update

25 iul. 2025, 16:45 UTC

Câștiguri

Apple Earnings Are Next Week. Why This Analyst Says Be Cautious. -- Barrons.com

25 iul. 2025, 16:27 UTC

Câștiguri

These Stocks Are Moving the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Tesla, and More -- Barrons.com

25 iul. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

25 iul. 2025, 16:02 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Berkshire Stock Is Losing Its Buffett Premium. Now Is the Time to Buy. -- Barrons.com

25 iul. 2025, 15:34 UTC

Câștiguri

Intel's Harsh Reality Nullifies Tariff Boost -- WSJ

25 iul. 2025, 15:06 UTC

Market Talk

Base Metal Prices Fall on Stronger U.S. Dollar -- Market Talk

25 iul. 2025, 15:05 UTC

Câștiguri

These Stocks Are Moving the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Comfort Systems, and More -- Barrons.com

25 iul. 2025, 14:45 UTC

Market Talk

Oil Rangebound Amid U.S.-EU Trade Uncertainty -- Market Talk

25 iul. 2025, 14:44 UTC

Market Talk

Gold Futures Set to End Week Lower on Easing Trade War Concerns -- Market Talk

25 iul. 2025, 14:36 UTC

Market Talk
Câștiguri

Phillips 66 CEO Says California Administration Supports of LA Plant Closure -- Market Talk

Comparație

Modificare preț

Cogent Biosciences Inc Așteptări

Obiectiv de preț

By TipRanks

62.72% sus

Prognoză pe 12 luni

Medie 19.64 USD  62.72%

Maxim 29 USD

Minim 9 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCogent Biosciences Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

12 ratings

9

Cumpărare

3

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

4.88 / 5.87Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Weak Bearish Evidence

Termen lung

Strong Bearish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Cogent Biosciences Inc

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.